Jazz Pharmaceuticals
JAZZ
JAZZ
470 hedge funds and large institutions have $7.04B invested in Jazz Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 146 increasing their positions, 165 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.91% less ownership
Funds ownership: 90.36% → 88.44% (-1.9%)
12% less repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 165
15% less capital invested
Capital invested by funds: $8.3B → $7.04B (-$1.26B)
Holders
470
Holding in Top 10
6
Calls
$11.7M
Puts
$12.4M
Top Buyers
| 1 | +$69.1M | |
| 2 | +$56.5M | |
| 3 | +$45.7M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$35.5M |
| 5 |
BlackRock
New York
|
+$27.6M |
Top Sellers
| 1 | -$78.3M | |
| 2 | -$58.4M | |
| 3 | -$53.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$44.7M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$37.3M |